New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
Glycosphingolipid lysosomal storage diseases are a small but challenging group of human disorders to treat. Although these appear to be monogenic disorders where the catalytic activity of enzymes in glycosphingolipid catabolism is impaired, the presentation and severity of disease is heterogeneous....
Những tác giả chính: | Butters, T, Dwek, R, Platt, F |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2003
|
Những quyển sách tương tự
-
Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
Bằng: Jeyakumar, M, et al.
Được phát hành: (2002) -
Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
Bằng: Butters, T, et al.
Được phát hành: (2000) -
Substrate deprivation: a new therapeutic approach for the glycosphingolipid lysosomal storage diseases.
Bằng: Platt, F, et al.
Được phát hành: (2000) -
New developments in treating glycosphingolipid storage diseases.
Bằng: Platt, F, et al.
Được phát hành: (2005) -
Glycosphingolipid profiling of tissues from mouse models of human lysosomal storage disorders
Bằng: Priestman, D, et al.
Được phát hành: (2008)